BCR/ABL Promotes Accumulation of Chromosomal Aberrations Induced by Oxidative and Genotoxic Stress

Overview

Journal Leukemia

Specialties Hematology
Oncology

Date 2008 Apr 11

PMID 18401418

Citations 43

Authors

M Koptyra

K Cramer

A Slupianek

C Richardson

T Skorski

Affiliations

Soon will be listed here.

Citing Articles

Oxidative Stress and Chronic Myeloid Leukemia: A Balance between ROS-Mediated Pro- and Anti-Apoptotic Effects of Tyrosine Kinase Inhibitors.

Allegra A, Mirabile G, Caserta S, Stagno F, Russo S, Pioggia G Antioxidants (Basel). 2024; 13(4).

PMID: 38671909 PMC: 11047441. DOI: 10.3390/antiox13040461.

Changes in antioxidant status and DNA repair capacity are corroborated with molecular alterations in malignant thyroid tissue of patients with papillary thyroid cancer.

Eng Z, Abdul Aziz A, Ng K, Mat Junit S Front Mol Biosci. 2023; 10:1237548.

PMID: 37692064 PMC: 10484572. DOI: 10.3389/fmolb.2023.1237548.

Modeling Global Genomic Instability in Chronic Myeloid Leukemia (CML) Using Patient-Derived Induced Pluripotent Stem Cells (iPSCs).

Telliam G, Desterke C, Imeri J, Mkacher R, Oudrhiri N, Balducci E Cancers (Basel). 2023; 15(9).

PMID: 37174060 PMC: 10177163. DOI: 10.3390/cancers15092594.

Impact of additional genetic abnormalities at diagnosis of chronic myeloid leukemia for first-line imatinib-treated patients receiving proactive treatment intervention.

Shanmuganathan N, Wadham C, Shahrin N, Feng J, Thomson D, Wang P Haematologica. 2023; 108(9):2380-2395.

PMID: 36951160 PMC: 10483360. DOI: 10.3324/haematol.2022.282184.

Modeling Blast Crisis Using Mutagenized Chronic Myeloid Leukemia-Derived Induced Pluripotent Stem Cells (iPSCs).

Imeri J, Desterke C, Marcoux P, Telliam G, Sanekli S, Barreau S Cells. 2023; 12(4).

PMID: 36831265 PMC: 9953961. DOI: 10.3390/cells12040598.

References

Nowicki M, Falinski R, Koptyra M, Slupianek A, Stoklosa T, Gloc E . BCR/ABL oncogenic kinase promotes unfaithful repair of the reactive oxygen species-dependent DNA double-strand breaks. Blood. 2004; 104(12):3746-53. DOI: 10.1182/blood-2004-05-1941. View

Johansson B, Fioretos T, Mitelman F . Cytogenetic and molecular genetic evolution of chronic myeloid leukemia. Acta Haematol. 2002; 107(2):76-94. DOI: 10.1159/000046636. View

Bacher U, Haferlach T, Hiddemann W, Schnittger S, Kern W, Schoch C . Additional clonal abnormalities in Philadelphia-positive ALL and CML demonstrate a different cytogenetic pattern at diagnosis and follow different pathways at progression. Cancer Genet Cytogenet. 2005; 157(1):53-61. DOI: 10.1016/j.cancergencyto.2004.06.011. View

Melo J, Barnes D . Chronic myeloid leukaemia as a model of disease evolution in human cancer. Nat Rev Cancer. 2007; 7(6):441-53. DOI: 10.1038/nrc2147. View

Nieborowska-Skorska M, Stoklosa T, Datta M, Czechowska A, Rink L, Slupianek A . ATR-Chk1 axis protects BCR/ABL leukemia cells from the lethal effect of DNA double-strand breaks. Cell Cycle. 2006; 5(9):994-1000. DOI: 10.4161/cc.5.9.2722. View

Penserga E, Skorski T . Fusion tyrosine kinases: a result and cause of genomic instability. Oncogene. 2006; 26(1):11-20. DOI: 10.1038/sj.onc.1209756. View

Richardson C, Stark J, Ommundsen M, Jasin M . Rad51 overexpression promotes alternative double-strand break repair pathways and genome instability. Oncogene. 2004; 23(2):546-53. DOI: 10.1038/sj.onc.1207098. View

Fabarius A, Haferlach C, Muller M, Erben P, Lahaye T, Giehl M . Dynamics of cytogenetic aberrations in Philadelphia chromosome positive and negative hematopoiesis during dasatinib therapy of chronic myeloid leukemia patients after imatinib failure. Haematologica. 2007; 92(6):834-7. DOI: 10.3324/haematol.11064. View

Deininger M, Cortes J, Paquette R, Park B, Hochhaus A, Baccarani M . The prognosis for patients with chronic myeloid leukemia who have clonal cytogenetic abnormalities in philadelphia chromosome-negative cells. Cancer. 2007; 110(7):1509-19. DOI: 10.1002/cncr.22936. View

10.

Skorski T, Nieborowska-Skorska M, Wlodarski P, Perrotti D, Martinez R, Wasik M . Blastic transformation of p53-deficient bone marrow cells by p210bcr/abl tyrosine kinase. Proc Natl Acad Sci U S A. 1996; 93(23):13137-42. PMC: 24059. DOI: 10.1073/pnas.93.23.13137. View

11.

Huang Q, Wu Y, Snyder D, Chang K, Slovak M, Gaal K . Clinical and pathologic analysis of 16 cases of relapsed chronic myeloid leukemia after stem cell transplantation. Am J Clin Pathol. 2007; 128(4):565-70. DOI: 10.1309/ECDWCRLG889K1GGD. View

12.

Jabbour E, Kantarjian H, Abruzzo L, OBrien S, Garcia-Manero G, Verstovsek S . Chromosomal abnormalities in Philadelphia chromosome negative metaphases appearing during imatinib mesylate therapy in patients with newly diagnosed chronic myeloid leukemia in chronic phase. Blood. 2007; 110(8):2991-5. DOI: 10.1182/blood-2007-01-070045. View

13.

Deutsch E, Dugray A, Abdulkarim B, Marangoni E, Maggiorella L, Vaganay S . BCR-ABL down-regulates the DNA repair protein DNA-PKcs. Blood. 2001; 97(7):2084-90. DOI: 10.1182/blood.v97.7.2084. View

14.

Peng Y, Zhang Q, Nagasawa H, Okayasu R, Liber H, Bedford J . Silencing expression of the catalytic subunit of DNA-dependent protein kinase by small interfering RNA sensitizes human cells for radiation-induced chromosome damage, cell killing, and mutation. Cancer Res. 2002; 62(22):6400-4. View

15.

Koptyra M, Falinski R, Nowicki M, Stoklosa T, Majsterek I, Nieborowska-Skorska M . BCR/ABL kinase induces self-mutagenesis via reactive oxygen species to encode imatinib resistance. Blood. 2006; 108(1):319-27. PMC: 1895841. DOI: 10.1182/blood-2005-07-2815. View

16.

Dash A, Williams I, Kutok J, Tomasson M, Anastasiadou E, Lindahl K . A murine model of CML blast crisis induced by cooperation between BCR/ABL and NUP98/HOXA9. Proc Natl Acad Sci U S A. 2002; 99(11):7622-7. PMC: 124303. DOI: 10.1073/pnas.102583199. View

17.

Mitani K, Ogawa S, Tanaka T, Miyoshi H, Kurokawa M, Mano H . Generation of the AML1-EVI-1 fusion gene in the t(3;21)(q26;q22) causes blastic crisis in chronic myelocytic leukemia. EMBO J. 1994; 13(3):504-10. PMC: 394839. DOI: 10.1002/j.1460-2075.1994.tb06288.x. View

18.

Preti H, OBrien S, Giralt S, Beran M, Pierce S, Kantarjian H . Philadelphia-chromosome-positive adult acute lymphocytic leukemia: characteristics, treatment results, and prognosis in 41 patients. Am J Med. 1994; 97(1):60-5. DOI: 10.1016/0002-9343(94)90049-3. View

19.

Brady N, Gaymes T, Cheung M, Mufti G, Rassool F . Increased error-prone NHEJ activity in myeloid leukemias is associated with DNA damage at sites that recruit key nonhomologous end-joining proteins. Cancer Res. 2003; 63(8):1798-805. View

20.

Papadopoulos P, Greenstein A, Gaffney R, Westbrook C, Wiedemann L . Characterization of the translocation breakpoint sequences in Philadelphia-positive acute lymphoblastic leukemia. Genes Chromosomes Cancer. 1990; 1(3):233-9. DOI: 10.1002/gcc.2870010308. View